These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38032893)

  • 21. Comprehensive comparison of stroke risk score performance: a systematic review and meta-analysis among 6 267 728 patients with atrial fibrillation.
    van der Endt VHW; Milders J; Penning de Vries BBL; Trines SA; Groenwold RHH; Dekkers OM; Trevisan M; Carrero JJ; van Diepen M; Dekker FW; de Jong Y
    Europace; 2022 Nov; 24(11):1739-1753. PubMed ID: 35894866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of State-of-the-Art Neural Network Survival Models with the Pooled Cohort Equations for Cardiovascular Disease Risk Prediction.
    Deng Y; Liu L; Jiang H; Peng Y; Wei Y; Zhou Z; Zhong Y; Zhao Y; Yang X; Yu J; Lu Z; Kho A; Ning H; Allen NB; Wilkins JT; Liu K; Lloyd-Jones DM; Zhao L
    BMC Med Res Methodol; 2023 Jan; 23(1):22. PubMed ID: 36694118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of the Pooled Cohort equations in a long-term cohort study of Hong Kong Chinese.
    Lee CH; Woo YC; Lam JK; Fong CH; Cheung BM; Lam KS; Tan KC
    J Clin Lipidol; 2015; 9(5):640-6.e2. PubMed ID: 26350809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation and recalibration of the Framingham cardiovascular disease risk models in an Australian Indigenous cohort.
    Hua X; McDermott R; Lung T; Wenitong M; Tran-Duy A; Li M; Clarke P
    Eur J Prev Cardiol; 2017 Oct; 24(15):1660-1669. PubMed ID: 28749178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular risk prediction tools for populations in Asia.
    ; Barzi F; Patel A; Gu D; Sritara P; Lam TH; Rodgers A; Woodward M
    J Epidemiol Community Health; 2007 Feb; 61(2):115-21. PubMed ID: 17234869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Machine-learning versus traditional approaches for atherosclerotic cardiovascular risk prognostication in primary prevention cohorts: a systematic review and meta-analysis.
    Liu W; Laranjo L; Klimis H; Chiang J; Yue J; Marschner S; Quiroz JC; Jorm L; Chow CK
    Eur Heart J Qual Care Clin Outcomes; 2023 Jun; 9(4):310-322. PubMed ID: 36869800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing 10-Year Cardiovascular Disease Risk in Malaysians With Type 2 Diabetes Mellitus: Framingham Cardiovascular Versus United Kingdom Prospective Diabetes Study Equations.
    Yew SQ; Chia YC; Theodorakis M
    Asia Pac J Public Health; 2019 Oct; 31(7):622-632. PubMed ID: 31535566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Traditional Cardiovascular Risk Factors Strongly Underestimate the 5-Year Occurrence of Cardiovascular Morbidity and Mortality in Spinal Cord Injured Individuals.
    Barton TJ; Low DA; Bakker EA; Janssen T; de Groot S; van der Woude L; Thijssen DHJ
    Arch Phys Med Rehabil; 2021 Jan; 102(1):27-34. PubMed ID: 32861666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the Incremental Value of a Coronary Artery Calcium Score Beyond Traditional Cardiovascular Risk Assessment: A Systematic Review and Meta-analysis.
    Bell KJL; White S; Hassan O; Zhu L; Scott AM; Clark J; Glasziou P
    JAMA Intern Med; 2022 Jun; 182(6):634-642. PubMed ID: 35467692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis.
    ; Fowkes FG; Murray GD; Butcher I; Heald CL; Lee RJ; Chambless LE; Folsom AR; Hirsch AT; Dramaix M; deBacker G; Wautrecht JC; Kornitzer M; Newman AB; Cushman M; Sutton-Tyrrell K; Fowkes FG; Lee AJ; Price JF; d'Agostino RB; Murabito JM; Norman PE; Jamrozik K; Curb JD; Masaki KH; Rodríguez BL; Dekker JM; Bouter LM; Heine RJ; Nijpels G; Stehouwer CD; Ferrucci L; McDermott MM; Stoffers HE; Hooi JD; Knottnerus JA; Ogren M; Hedblad B; Witteman JC; Breteler MM; Hunink MG; Hofman A; Criqui MH; Langer RD; Fronek A; Hiatt WR; Hamman R; Resnick HE; Guralnik J; McDermott MM
    JAMA; 2008 Jul; 300(2):197-208. PubMed ID: 18612117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of the SCORE and Globorisk cardiovascular risk prediction models: a prospective cohort study in Dutch general practice.
    Schoofs MC; Akkermans RP; de Grauw WJ; Schalk BW; van Dis I; Tjin-A-Ton J; Bischoff EW; Biermans MC
    Br J Gen Pract; 2023 Jan; 73(726):e24-e33. PubMed ID: 36443066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of the American Heart Association/American College of Cardiology Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Self-reported Physical Activity Levels.
    Pandey A; Mehta A; Paluch A; Ning H; Carnethon MR; Allen NB; Michos ED; Berry JD; Lloyd-Jones DM; Wilkins JT
    JAMA Cardiol; 2021 Jun; 6(6):690-696. PubMed ID: 33909016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study.
    Davis WA; Colagiuri S; Davis TM
    Med J Aust; 2009 Feb; 190(4):180-4. PubMed ID: 19220181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incorporating Frailty Into the Pooled Cohort Equations to Predict Cardiovascular Disease Among Persons With HIV.
    Kelly SG; Wu K; Tassiopoulos K; Erlandson KM; Koletar SL; Palella FJ;
    J Acquir Immune Defic Syndr; 2021 Jul; 87(3):971-977. PubMed ID: 33625065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of China-PAR and Framingham risk score in assessment of 10-year cardiovascular disease risk in Chinese hypertensive patients.
    Chen X; Tu Q; Wang D; Liu J; Qin Y; Zhang Y; Xiang Q
    Public Health; 2023 Jul; 220():127-134. PubMed ID: 37315498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.
    Vernooij LM; van Klei WA; Moons KG; Takada T; van Waes J; Damen JA
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013139. PubMed ID: 34931303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients With Stable Coronary Heart Disease.
    Ganz P; Heidecker B; Hveem K; Jonasson C; Kato S; Segal MR; Sterling DG; Williams SA
    JAMA; 2016 Jun; 315(23):2532-41. PubMed ID: 27327800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic validation of a non-laboratory and a laboratory based cardiovascular disease risk score in multiple regions of the world.
    Joseph P; Yusuf S; Lee SF; Ibrahim Q; Teo K; Rangarajan S; Gupta R; Rosengren A; Lear SA; Avezum A; Lopez-Jaramillo P; Gulec S; Yusufali A; Chifamba J; Lanas F; Kumar R; Mohammadifard N; Mohan V; Mony P; Kruger A; Liu X; Guo B; Zhao W; Yang Y; Pillai R; Diaz R; Krishnapillai A; Iqbal R; Yusuf R; Szuba A; Anand SS;
    Heart; 2018 Apr; 104(7):581-587. PubMed ID: 29066611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis.
    Allotey J; Snell KI; Smuk M; Hooper R; Chan CL; Ahmed A; Chappell LC; von Dadelszen P; Dodds J; Green M; Kenny L; Khalil A; Khan KS; Mol BW; Myers J; Poston L; Thilaganathan B; Staff AC; Smith GC; Ganzevoort W; Laivuori H; Odibo AO; Ramírez JA; Kingdom J; Daskalakis G; Farrar D; Baschat AA; Seed PT; Prefumo F; da Silva Costa F; Groen H; Audibert F; Masse J; Skråstad RB; Salvesen KÅ; Haavaldsen C; Nagata C; Rumbold AR; Heinonen S; Askie LM; Smits LJ; Vinter CA; Magnus PM; Eero K; Villa PM; Jenum AK; Andersen LB; Norman JE; Ohkuchi A; Eskild A; Bhattacharya S; McAuliffe FM; Galindo A; Herraiz I; Carbillon L; Klipstein-Grobusch K; Yeo S; Teede HJ; Browne JL; Moons KG; Riley RD; Thangaratinam S
    Health Technol Assess; 2020 Dec; 24(72):1-252. PubMed ID: 33336645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular risk prediction models for women in the general population: A systematic review.
    Baart SJ; Dam V; Scheres LJJ; Damen JAAG; Spijker R; Schuit E; Debray TPA; Fauser BCJM; Boersma E; Moons KGM; van der Schouw YT;
    PLoS One; 2019; 14(1):e0210329. PubMed ID: 30620772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.